相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors
Christopher S. Wilcox
HYPERTENSION (2020)
Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy
Hitomi Otomo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function
Giuseppe Pugliese et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Population dietary salt reduction and the risk of cardiovascular disease. A scientific statement from the European Salt Action Network
F. P. Cappuccio et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2019)
Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells
Toshinobu Maki et al.
SCIENTIFIC REPORTS (2019)
Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
Michitsugu Kamezaki et al.
SCIENTIFIC REPORTS (2018)
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
Aleksandra Novikov et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
David Cherney et al.
DIABETOLOGIA (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice (vol 6, 26428, 2016)
Linda A. Gallo et al.
SCIENTIFIC REPORTS (2016)
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
Vasilios Papademetriou et al.
KIDNEY INTERNATIONAL (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
Thaissa Dantas Pessoa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Dapagliflozin for the treatment of type 2 diabetes: a review of the literature
Mujahid A. Saeed et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
Low Salt Intake and Changes in Serum Sodium Levels in the Combination Therapy of Low-Dose Hydrochlorothiazide and Angiotensin II Receptor Blocker
Masafumi Nakayama et al.
CIRCULATION JOURNAL (2013)
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
H. J. Lambers Heerspink et al.
DIABETES OBESITY & METABOLISM (2013)
High salt intake promotes a decline in renal function in hypertensive patients: a 10-year observational study
Yuko Ohta et al.
HYPERTENSION RESEARCH (2013)
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
Ian H. de Boer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
Volker Vallon et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials
Yu Pan et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Report of the working group for dietary salt reduction of the Japanese society of hypertension: (2) Assessment of salt intake in the management of hypertension
Yuhei Kawano et al.
HYPERTENSION RESEARCH (2007)
Diabetic retinopathy and the risk of coronary heart disease - The Atherosclerosis Risk in Communities Study
Ning Cheung et al.
DIABETES CARE (2007)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
HH Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
